|
Volumn 49, Issue 8, 1996, Pages 782-799
|
Clinical studies on vancomycin in the treatment of MRSA infection
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ASPOXICILLIN;
BETA LACTAM ANTIBIOTIC;
CEFOPERAZONE;
CEFOTIAM;
CEFPIROME;
CEFSULODIN;
CEFTAZIDIME;
CILASTATIN PLUS IMIPENEM;
CIPROFLOXACIN;
CLINDAMYCIN;
FLOMOXEF;
FOSFOMYCIN;
GENTAMICIN;
ISEPAMICIN;
LATAMOXEF;
MINOCYCLINE;
PANIPENEM PLUS BETAMIPRON;
PIPERACILLIN;
TOSUFLOXACIN;
VANCOMYCIN;
ADOLESCENT;
ADULT;
AGED;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE KIDNEY FUNCTION RELATION;
DOSE LIVER FUNCTION RELATION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG SAFETY;
ERYTHEMA;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
RASH;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS INFECTION;
ADOLESCENT;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
LACTAMS;
MALE;
METHICILLIN RESISTANCE;
MIDDLE AGED;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
VANCOMYCIN;
|
EID: 0029742902
PISSN: 03682781
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (0)
|